1st June, 2022

Phupinder Gill, a former chief executive of CME Group, has taken a role at a new medical derivatives exchange that applied for US approval on Tuesday
Access this article plus the full FOW Intelligence platform, featuring timely insights, expert analysis, and comprehensive volumes data from 100+ exchanges. Everything you need to make informed decisions.
Already have an account?Log in
